tiprankstipranks

New Portfolio - New Portfolio

Akhtam A

New Portfolio
Individual Investor
Ranked #573,503 out of 723,149 TipRanks' Investors
Success Rate
40%
84 out of 212
profitable transactions
Average Return
-17.48%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 0.04%
6-Month Return▲ 40.58%
12-Month Return▲ 30.99%
YTD Return▲ 15.21%
Total Return▼ 7.01%

Best Trade

Opened at
Closed at
Gain▲ 480.56%

Bio

Individual Investor

Performance

16.00%0-16.00%
▼ 8.63%
▼ 1.63%
▼ 7.64%
Aug 2023
▼ 4.52%
▼ 4.74%
▼ 9.05%
Sep 2023
▼ 6.45%
▼ 2.17%
▼ 7.07%
Oct 2023
▲ 9.22%
▲ 9.13%
▲ 13.20%
Nov 2023
▲ 5.14%
▲ 4.57%
▲ 16.00%
Dec 2023
▼ 1.87%
▲ 1.59%
▼ 0.29%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 15.50%
Feb 2024
▲ 1.35%
▲ 3.29%
▲ 0.04%
Mar 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 8.63%▼ 1.63%▼ 7.64%
▼ 4.52%▼ 4.74%▼ 9.05%
▼ 6.45%▼ 2.17%▼ 7.07%
▲ 9.22%▲ 9.13%▲ 13.20%
▲ 5.14%▲ 4.57%▲ 16.00%
▼ 1.87%▲ 1.59%▼ 0.29%
▲ 14.08%▲ 5.22%▲ 15.50%
▲ 1.35%▲ 3.29%▲ 0.04%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
w0168m3n8z
w0168m3n8z
w0168m3n8z
w0168m3n8z
w0168m3n8z
w0168m3n8z
w0168m3n8z
j1kbgwhlh8
j1kbgwhlh8
j1kbgwhlh8
j1kbgwhlh8
j1kbgwhlh8
j1kbgwhlh8
j1kbgwhlh8
dahv414iygq
dahv414iygq
dahv414iygq
dahv414iygq
dahv414iygq
dahv414iygq
dahv414iygq
xpdxnpe7
xpdxnpe7
xpdxnpe7
xpdxnpe7
xpdxnpe7
xpdxnpe7
xpdxnpe7
9pasvr4e7qw
9pasvr4e7qw
9pasvr4e7qw
9pasvr4e7qw
9pasvr4e7qw
9pasvr4e7qw
9pasvr4e7qw
w3f2pdrfc1c
w3f2pdrfc1c
w3f2pdrfc1c
w3f2pdrfc1c
w3f2pdrfc1c
w3f2pdrfc1c
w3f2pdrfc1c
am862vkb9qp
am862vkb9qp
am862vkb9qp
am862vkb9qp
am862vkb9qp
am862vkb9qp
am862vkb9qp
0ikkpi1yycw
0ikkpi1yycw
0ikkpi1yycw
0ikkpi1yycw
0ikkpi1yycw
0ikkpi1yycw
0ikkpi1yycw
23owbmt4xon
23owbmt4xon
23owbmt4xon
23owbmt4xon
23owbmt4xon
23owbmt4xon
23owbmt4xon
o4l1nduon
o4l1nduon
o4l1nduon
o4l1nduon
o4l1nduon
o4l1nduon
o4l1nduon
To view investors' portfolios
Sign Up For Free
Alteryx
▼ 56.44%
4
Close
Mar 18, 2024
Eargo
▼ 99.51%
3
Close
Feb 15, 2024
Intercept Pharma
▼ 12.36%
2
Close
Nov 07, 2023
Zynerba Pharmaceuticals
▼ 59.52%
6
Close
Oct 10, 2023
Reata Pharmaceuticals
▲ 264.54%
5
Close
Aug 25, 2023
TCR2 Therapeutics
▼ 94.53%
2
Close
May 31, 2023
Adaptimmune Therapeutics
0.26%
▲ 54.90%
1
Open
May 31, 2023
Velodyne Lidar
▼ 80.91%
2
Close
Feb 10, 2023
Ouster
0.18%
▼ 56.21%
1
Open
Feb 10, 2023
Micro Focus International
▲ 35.31%
3
Close
Jan 31, 2023
China Life Insurance Company
▼ 28.41%
3
Close
Nov 10, 2022
Global Blood Therapeutics
▲ 111.00%
2
Close
Oct 05, 2022
Turning Point Therapeutics
▲ 77.26%
2
Close
Aug 16, 2022
Warner Bros
0.72%
▼ 65.13%
1
Open
Apr 11, 2022
Palantir Technologies
0.32%
▲ 67.53%
1
Open
Apr 04, 2022
Vale SA
▲ 53.44%
6
Close
Mar 28, 2022
Corcept Therapeutics
▲ 31.30%
2
Close
Mar 28, 2022
SAGE Therapeutics
0.78%
▼ 48.40%
2
Buy
Feb 22, 2022
Meta Platforms
20.1%
▲ 133.45%
2
Buy
Feb 18, 2022
Editas Medicine
0.2%
▼ 51.05%
1
Open
Feb 18, 2022